HypertensionNCT06401759
Use of Podcasts in the Education of Hypertension Patients
A study testing Podcast in people with Hypertension, run by Firat University at 1 site in Turkey (Türkiye).
Trial summary
Hypertension is an important public health problem all over the world due to its high prevalence and its association with increased risk of cardiovascular disease. At the same time, it is a condition in which acquired factors, genetic and metabolic disorders, characterized by increased intra-arterial blood pressure… Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Hypertension
- What is being tested?
- Podcast
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 94 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Dec 2024to 1 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Education level must be at least primary school level.
- Patients with or without treatment experience
- Being between the ages of 18 and 65
- Being diagnosed with hypertension at least 6 months ago
- Being using at least one hypertensive drug
- Having enough internet to listen to podcasts on Spotify
Show all 9Show fewer
- Have Spotify supported devices (iOS 14 or above, Android OS 5.0 or above, OS X 10.15 or above, Windows 10 or above)
- Being competent in using a mobile phone
- Having 18.64 points and above in e-health literacy assessment
Who cannot join
- Those who have physical (speech, hearing impairment, etc.), neurological and psychological problems that prevent them from filling out research forms and participating in training.
- Those who do not have sufficient equipment (mobile phone or computer with internet connection) for podcast training
- Intervention group patients who do not listen to podcasts on Spotify (patients who do not fill out verbally or Google forms (Diary))
- Patients in the control group who were understood to have logged in to their account on Spotify and listened to podcasts.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Use of Podcasts in the Education of Hypertension Patients: A Randomized Controlled Study
Hypertension is an important public health problem all over the world due to its high prevalence and its association with increased risk of cardiovascular disease. At the same time, it is a condition in which acquired factors, genetic and metabolic disorders, characterized by increased intra-arterial blood pressure, occur together . According to the World Health Organization, hypertension is defined as systolic blood pressure of 140 mmHg and diastolic blood pressure of 90 mmHg or above According to the Arterial Hypertension Management 2018 Implementation Guide of the European Society of Cardiology and the European Society of Hypertension, it is estimated that there are more than 1 billion hypertension patients in the world and this number will reach 1.5 billion by 2025. In our country, there are approximately 20 million individuals with hypertension. It is thought to be Hypertension treatment is a lifelong process that includes lifestyle changes and patient education along with medical treatment.Turkish Endocrinology and Metabolism.
The aim of hypertension treatment is to ensure that blood pressure decreases to the targeted level, to minimize target organ damage and complications caused by hypertension, to eliminate symptoms and reduce drug side effects, to ensure patient compliance with treatment and to provide self-management skills by enabling the patient to take an active role in his own treatment. The concept of self-management; It includes providing individuals with knowledge and skills regarding disease management, providing support to maintain the individual's self-care, supporting the decision-making process, and helping to recognize and cope with problems. The main goal in hypertension treatment is to control the patient's blood pressure. Achieving and maintaining self-management is also one of the most effective factors in controlling blood pressure. Inadequately treated and low self-management In hypertension patients, blood pressure control is inadequate and health risks increase. Therefore, all strategies implemented to increase self-management in hypertension patients also have positive effects on the individual's blood pressure control and disease prognosis.
- Conditions
- Hypertension
- Being tested
- Podcast
- Keywords
- Podcast
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PodcastBehavioural
Also called Control
Routine maintenance will be applied.
| Study group | Role | What they receive |
|---|---|---|
| Podcast | Experimental | Not described Receives: Behavioral: Podcast |
| Control | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hill Bone Hypertension Treatment Compliance Scale
Measures treatment compliance of hypertension patients. was developed for evaluation. The Cronbach's Alpha value of the scale was found to be between 0.74 and 0.84. The scale is a 4-point Likert type and consists of 14 items and 3 sub-dimensions. The subscales of the scale are Interview (6th, 7th and 8th Questions), Medical (1st, 2nd, 9th, 10th, 11th, 12th, 13th and 14th Questions) and Nutrition (3rd, 14th Questions). 4th and 5th Questions). Question 6 on the scale is reverse coded. The total score range on the scale varies between 0 and 42. If the person gives the most positive answers to all questions and receives a total of 0 points, he or she is considered fully compliant. Scores outside zero indicate the degree of non-compliance. Since the questions are in the negative type of questions, the compliance decreases as the score increases.
Measured: Before and 12 weeks after application
Self-Care Management Scale in Chronic Diseases
It was developed to evaluate self-care management in chronic diseases. (The scale has a 5-point Likert structure (1=strongly disagree, 2=disagree, 3=undecided, 4=agree, 5=strongly agree) and consists of 35 items. The scale consists of two sub-dimensions. These sub-dimensions are: "self-protection" ( articles 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and "social protection" (articles 1, 3, 4, 5, 7, 9, 10, 12, 13 , 14, 16, 17, 21, 24 and 35 items. The 3rd, 15th, 19th and 28th items in the scale are negative expressions. The total scores that can be obtained from the scale vary between 35 and 175 points. It indicates that the individual's self-care management also increases
Measured: Before and 12 weeks after application
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2024
- Study start1 Dec 2024
- Primary completion1 Mar 2025
- Study completion1 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 94 participants (actual)
Sponsor and investigators
- Lead sponsor
- Firat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gülcan Bahçecioğlu Turan, Firat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06401759
- Sponsor's protocol ID
- 2024/04-47
- Status last verified
- Nov 2025
- First submitted
- 2 May 2024
- Last updated
- 18 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: after the project is finished
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of Podcasts in the Education of Hypertension Patients: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT06401759
- Acronym / sponsor ID
- 2024/04-47
- Conditions
- Hypertension
- Keywords
- Podcast
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 94 participants (actual)
- Lead sponsor
- Firat UniversityUniversity, hospital or other
- Study start
- 1 Dec 2024 (actual)
- Primary completion
- 1 Mar 2025 (actual)
- Study completion
- 1 Aug 2025 (actual)
- First posted
- 7 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypertension is an important public health problem all over the world due to its high prevalence and its association with increased risk of cardiovascular disease. At the same time, it is a condition in which acquired factors, genetic and metabolic disorders, characterized by increased intra-arterial blood pressure, occur together . According to the World Health Organization, hypertension is defined as systolic blood pressure of 140 mmHg and diastolic blood pressure of 90 mmHg or above According to the Arterial Hypertension Management 2018 Implementation Guide of the European Society of Cardiology and the European Society of Hypertension, it is estimated that there are more than 1 billion hypertension patients in the world and this number will reach 1.5 billion by 2025. In our country, there are approximately 20 million individuals with hypertension. It is thought to be Hypertension treatment is a lifelong process that includes lifestyle changes and patient education along with medical treatment.Turkish Endocrinology and Metabolism.
The aim of hypertension treatment is to ensure that blood pressure decreases to the targeted level, to minimize target organ damage and complications caused by hypertension, to eliminate symptoms and reduce drug side effects, to ensure patient compliance with treatment and to provide self-management skills by enabling the patient to take an active role in his own treatment. The concept of self-management; It includes providing individuals with knowledge and skills regarding disease management, providing support to maintain the individual's self-care, supporting the decision-making process, and helping to recognize and cope with problems. The main goal in hypertension treatment is to control the patient's blood pressure. Achieving and maintaining self-management is also one of the most effective factors in controlling blood pressure. Inadequately treated and low self-management In hypertension patients, blood pressure control is inadequate and health risks increase. Therefore, all strategies implemented to increase self-management in hypertension patients also have positive effects on the individual's blood pressure control and disease prognosis.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Podcast | Experimental | Behavioral: Podcast |
| Control | No intervention | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Education level must be at least primary school level.
- Patients with or without treatment experience
- Being between the ages of 18 and 65
- Being diagnosed with hypertension at least 6 months ago
- Being using at least one hypertensive drug
Key exclusion criteria (4 listed)
- Those who have physical (speech, hearing impairment, etc.), neurological and psychological problems that prevent them from filling out research forms and participating in training.
- Those who do not have sufficient equipment (mobile phone or computer with internet connection) for podcast training
- Intervention group patients who do not listen to podcasts on Spotify (patients who do not fill out verbally or Google forms (Diary))
- Patients in the control group who were understood to have logged in to their account on Spotify and listened to podcasts.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PodcastAlso: ControlRoutine maintenance will be applied. | Behavioural | Podcast |
Primary outcome
Hill Bone Hypertension Treatment Compliance Scale
Time frame: Before and 12 weeks after application
Measures treatment compliance of hypertension patients. was developed for evaluation. The Cronbach's Alpha value of the scale was found to be between 0.74 and 0.84. The scale is a 4-point Likert type and consists of 14 items and 3 sub-dimensions. The subscales of the scale are Interview (6th, 7th and 8th Questions), Medical (1st, 2nd, 9th, 10th, 11th, 12th, 13th and 14th Questions) and Nutrition (3rd, 14th Questions). 4th and 5th Questions). Question 6 on the scale is reverse coded. The total score range on the scale varies between 0 and 42. If the person gives the most positive answers to all questions and receives a total of 0 points, he or she is considered fully compliant. Scores outside zero indicate the degree of non-compliance. Since the questions are in the negative type of questions, the compliance decreases as the score increases.
Self-Care Management Scale in Chronic Diseases
Time frame: Before and 12 weeks after application
It was developed to evaluate self-care management in chronic diseases. (The scale has a 5-point Likert structure (1=strongly disagree, 2=disagree, 3=undecided, 4=agree, 5=strongly agree) and consists of 35 items. The scale consists of two sub-dimensions. These sub-dimensions are: "self-protection" ( articles 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and "social protection" (articles 1, 3, 4, 5, 7, 9, 10, 12, 13 , 14, 16, 17, 21, 24 and 35 items. The 3rd, 15th, 19th and 28th items in the scale are negative expressions. The total scores that can be obtained from the scale vary between 35 and 175 points. It indicates that the individual's self-care management also increases
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2025.
- Individual participant dataSharing planned: No. after the project is finished
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Podcast in people with Hypertension, run by Firat University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hill Bone Hypertension Treatment Compliance Scale (time frame: Before and 12 weeks after application). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.